Therapeutic prospects to treat skeletal muscle wasting in COPD (chronic obstructive lung disease)

Pharmacology and Therapeutics

Volumn 109, Issue 1-2, 2006, Pages 162-172

  Hansen, Michelle J ^a   Gualano, Rosa C ^a   Bozinovski, Steve ^a   Vlahos, Ross ^a   Anderson, Gary P ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Chronic obstructive pulmonary disease (COPD); Skeletal muscle; Therapeutic strategies; Wasting

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANABOLIC AGENT; ANTIOXIDANT; ATLIZUMAB; BIOFLAVONOID; BORTEZOMIB; CT 20026; CT 99021; CYTOKINE; CYTOKINE RECEPTOR ANTAGONIST; DIETHYLDITHIOCARBAMIC ACID; ETANERCEPT; GHRELIN; GLUCOCORTICOID; GROWTH HORMONE; I KAPPA B; I KAPPA B KINASE INHIBITOR; INDIRUBIN; INFLIXIMAB; INTERLEUKIN 15; MYO 029; NANDROLONE; PROANTHOCYANIDIN; PROTEASOME INHIBITOR; RETINOL; SALICYLIC ACID DERIVATIVE; SOMATOMEDIN C; TESTOSTERONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

APOPTOSIS; BODY MASS; CELL ACTIVATION; CELL DIFFERENTIATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; DISEASE CLASSIFICATION; DISEASE SEVERITY; HUMAN; LIFE EXPECTANCY; LUNG FUNCTION; LUNG STRUCTURE; MORBIDITY; MUSCLE ATROPHY; MUSCLE MASS; MYOBLAST; NONHUMAN; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE;

ANIMALS; HORMONES; HUMANS; INFLAMMATION; LUNG; MUSCLE, SKELETAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; WASTING SYNDROME;

EID: 28444474549     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2005.06.007     Document Type: Review

References (82)

1. S.D. Aaron, J.B. Angel, M. Lunau, K. Wright, C. Fex, and N. Le Saux Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease Am J Respir Crit Care Med 163 2001 349 355
2. Y. Adachi, C.T. Lee, and D.P. Carbone Genetic blockade of the insulin-like growth factor 1 receptor for human malignancy Novartis Found Symp 262 2004 177 189
3. A.G. Agusti, J. Sauleda, C. Miralles, C. Gomez, B. Togores, and E. Sala Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease Am J Respir Crit Care Med 166 2002 485 489
4. A.M. Ahtikoski, E.M. Riso, S.O. Koskinen, J. Risteli, and T.E. Takala Regulation of type IV collagen gene expression and degradation in fast and slow muscles during dexamethasone treatment and exercise Pflugers Arch 448 2004 123 130
5. J. Allaire, F. Maltais, J.F. Doyon, M. Noel, P. LeBlanc, and G. Carrier Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD Thorax 59 2004 673 678
6. American Thoracic Society/European Respiratory Society (ATS/ERS Skeletal muscle dysfunction in chronic obstructive pulmonary disease Am J Respir Crit Care Med 159 1999 S1 S40
7. P.J. Barnes, S.D. Shapiro, and R.A. Pauwels Chronic obstructive pulmonary disease: molecular and cellular mechanisms Eur Respir J 22 2003 672 688
8. P.J. Barnes, K. Ito, and I.M. Adcock Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase Lancet 363 2004 731 733
9. A. Bhowmik, T.A. Seemungal, R.J. Sapsford, and J.A. Wedzicha Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations Thorax 55 2000 114 120
10. M.R. Blackman, J.D. Sorkin, T. Munzer, M.F. Bellantoni, J. Busby-Whitehead, and T.E. Stevens Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial JAMA 288 2002 2282 2292
11. S.C. Bodine, E. Latres, S. Baumhueter, V.K. Lai, L. Nunez, and B.A. Clarke Identification of ubiquitin ligases required for skeletal muscle atrophy Science 294 2001 1704 1708
12. S.C. Bodine, T.N. Stitt, M. Gonzalez, W.O. Kline, G.L. Stover, and R. Bauerlein Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo Nat Cell Biol 3 2001 1014 1019
13. S. Bogdanovich, T.O. Krag, E.R. Barton, L.D. Morris, L.A. Whittemore, and R.S. Ahima Functional improvement of dystrophic muscle by myostatin blockade Nature 420 2002 418 421
14. S. Bogdanovich, K.J. Perkins, T.O. Krag, L.A. Whittemore, and T.S. Khurana Myostatin propeptide-mediated amelioration of dystrophic pathophysiology FASEB J 19 2005 543 549
15. S. Bozinovski, J.E. Jones, R. Vlahos, J.A. Hamilton, and G.P. Anderson Granulocyte/macrophage-colony-stimulating factor (GM-CSF) regulates lung innate immunity to lipopolysaccharide through Akt/Erk activation of NFkappa B and AP-1 in vivo J Biol Chem 277 2002 42808 42814
16. R. Broekhuizen, J.H. Vernooy, A.M. Schols, M.A. Dentener, and E.F. Wouters Leptin as local inflammatory marker in COPD Respir Med 99 2005 70 74
17. L. Burdet, B. de Muralt, Y. Schutz, C. Pichard, and J.W. Fitting Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study Am J Respir Crit Care Med 156 1997 1800 1806
18. E. Carmeli, M. Moas, A.Z. Reznick, and R. Coleman Matrix metalloproteinases and skeletal muscle: a brief review Muscle Nerve 29 2004 191 197
19. R. Casaburi, S. Bhasin, L. Cosentino, J. Porszasz, A. Somfay, and M.I. Lewis Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease Am J Respir Crit Care Med 170 2004 870 878
20. B.R. Celli, C.G. Cote, J.M. Marin, C. Casanova, M. Montes de Oca, and R.A. Mendez The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease N Engl J Med 350 2004 1005 1012
21. M.V. Chakravarthy, B.S. Davis, and F.W. Booth IGF-I restores satellite cell proliferative potential in immobilized old skeletal muscle J Appl Physiol 89 2000 1365 1379
22. S.B. Charge, and M.A. Rudnicki Cellular and molecular regulation of muscle regeneration Physiol Rev 84 2004 209 238
23. W.S. Chen, P.Z. Xu, K. Gottlob, M.L. Chen, K. Sokol, and T. Shiyanova Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene Genes Dev 15 2001 2203 2208
24. H. Chen, R. Vlahos, S. Bozinovski, J. Jones, G.P. Anderson, and M.J. Morris Effect of short-term cigarette smoke exposure on body weight, appetite and brain neuropeptide Y in mice Neuropsychopharmacology 30 2005 713 719
25. L. Combaret, D. Taillandier, D. Dardevet, D. Bechet, C. Ralliere, and A. Claustre Glucocorticoids regulate mRNA levels for subunits of the 19 S regulatory complex of the 26 S proteasome in fast-twitch skeletal muscles Biochem J 378 2004 239 246
26. E.C. Creutzberg, E.F. Wouters, I.M. Vanderhoven-Augustin, M.A. Dentener, and A.M. Schols Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease Am J Respir Crit Care Med 162 2000 1239 1245
27. S.W. Crooks, D.L. Bayley, S.L. Hill, and R.A. Stockley Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4 Eur Respir J 15 2000 274 280
28. V.D. Dixit, E.M. Schaffer, R.S. Pyle, G.D. Collins, S.K. Sakthivel, and R. Palaniappan Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells J Clin Invest 114 2004 57 66
29. A.G. Drannik, M.A. Pouladi, C.S. Robbins, S.I. Goncharova, S. Kianpour, and M.R. Stampfli Impact of cigarette smoke on clearance and inflammation after Pseudomonas aeruginosa infection Am J Respir Crit Care Med 170 2004 1164 1171
30. M.P. Engelen, A.M. Schols, J.D. Does, N.E. Deutz, and E.F. Wouters Altered glutamate metabolism is associated with reduced muscle glutathione levels in patients with emphysema Am J Respir Crit Care Med 161 2000 98 103
31. M. Ernst, and B.J. Jenkins Acquiring signalling specificity from the cytokine receptor gp130 Trends Genet 20 2004 23 32
32. C.H. Fang, B.G. Li, X. Sun, and P.O. Hasselgren Insulin-like growth factor I reduces ubiquitin and ubiquitin-conjugating enzyme gene expression but does not inhibit muscle proteolysis in septic rats Endocrinology 141 2000 2743 2751
33. I.M. Ferreira, I.T. Verreschi, L.E. Nery, R.S. Goldstein, N. Zamel, and D. Brooks The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients Chest 114 1998 19 28
34. W.Q. Gan, S.F. Man, A. Senthilselvan, and D.D. Sin Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis Thorax 59 2004 574 580
35. N.F. Gonzalez-Cadavid, W.E. Taylor, K. Yarasheski, I. Sinha-Hikim, K. Ma, and S. Ezzat Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting Proc Natl Acad Sci U S A 95 1998 14938 14943
36. M.N. Goodman Interleukin-6 induces skeletal muscle protein breakdown in rats Proc Soc Exp Biol Med 205 1994 182 185
37. H.R. Gosker, B. Kubat, G. Schaart, G.J. van der Vusse, E.F. Wouters, and A.M. Schols Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease Eur Respir J 22 2003 280 285
38. D.C. Guttridge, M.W. Mayo, L.V. Madrid, C.Y. Wang, and A.S. Baldwin Jr. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia Science 289 2000 2363 2366
39. F. Haddad, F. Zaldivar, D.M. Cooper, and G.R. Adams IL-6-induced skeletal muscle atrophy J Appl Physiol 98 2005 911 917
40. M.J. Hansen, M.J. Ball, and M.J. Morris Enhanced inhibitory feeding response to alpha-melanocyte stimulating hormone in the diet-induced obese rat Brain Res 892 2001 130 137
41. M.J. Hansen, V. Jovanovska, and M.J. Morris Adaptive responses in hypothalamic neuropeptide Y in the face of prolonged high-fat feeding in the rat J Neurochem 88 2004 909 916
42. P.J. Havel, S. Kasim-Karakas, W. Mueller, P.R. Johnson, R.L. Gingerich, and J.S. Stern Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss J Clin Endocrinol Metab 81 1996 4406 4413
43. T.J. Hawke, and D.J. Garry Myogenic satellite cells: physiology to molecular biology J Appl Physiol 91 2001 534 551
44. E.P. Hoffman, and G.A. Nader Balancing muscle hypertrophy and atrophy Nat Med 10 2004 584 585
45. T. Itoh, N. Nagaya, M. Yoshikawa, A. Fukuoka, H. Takenaka, and Y. Shimizu Elevated plasma ghrelin level in underweight patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 170 2004 879 882
46. D. Joulia, H. Bernardi, V. Garandel, F. Rabenoelina, B. Vernus, and G. Cabello Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin Exp Cell Res 286 2003 263 275
47. S. Kherif, C. Lafuma, M. Dehaupas, S. Lachkar, J.G. Fournier, and M. Verdiere-Sahuque Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: a study in experimentally injured and mdx muscles Dev Biol 205 1999 158 170
48. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa Ghrelin is a growth-hormone-releasing acylated peptide from stomach Nature 402 1999 656 660
49. S.O. Koskinen, W. Wang, A.M. Ahtikoski, M. Kjaer, X.Y. Han, and J. Komulainen Acute exercise induced changes in rat skeletal muscle mRNAs and proteins regulating type IV collagen content Am J Physiol Regul Integr Comp Physiol 280 2001 R1292 R1300
50. K.M. Lai, M. Gonzalez, W.T. Poueymirou, W.O. Kline, E. Na, and E. Zlotchenko Conditional activation of Akt in adult skeletal muscle induces rapid hypertrophy Mol Cell Biol 24 2004 9295 9304
51. R.C. Langen, A.M. Schols, M.C. Kelders, J.L. Van Der Velden, E.F. Wouters, and Y.M. Janssen-Heininger Tumor necrosis factor-alpha inhibits myogenesis through redox-dependent and -independent pathways Am J Physiol Cell Physiol 283 2002 C714 C721
52. R.C. Langen, J.L. Van Der Velden, A.M. Schols, M.C. Kelders, E.F. Wouters, and Y.M. Janssen-Heininger Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization FASEB J 18 2004 227 237
53. P.R. Ling, J.H. Schwartz, and B.R. Bistrian Mechanisms of host wasting induced by administration of cytokines in rats Am J Physiol 272 1997 E333 E339
54. M. Llovera, C. Garcia-Martinez, N. Agell, F.J. Lopez-Soriano, and J.M. Argiles TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles Biochem Biophys Res Commun 230 1997 238 241
55. P.E. Lonning, and S.I. Helle IGF-1 and breast cancer Novartis Found Symp 262 2004 205 212
56. A.D. Lopez, and C.C. Murray The global burden of disease, 1990-2020 Nat Med 4 1998 1241 1243
57. F. Maltais, P. LeBlanc, F. Whittom, C. Simard, K. Marquis, and M. Belanger Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD Thorax 55 2000 848 853
58. S. McCroskery, M. Thomas, L. Maxwell, M. Sharma, and R. Kambadur Myostatin negatively regulates satellite cell activation and self-renewal J Cell Biol 162 2003 1135 1147
59. C.E. McEvoy, and D.E. Niewoehner Adverse effects of corticosteroid therapy for COPD. A critical review Chest 111 1997 732 743
60. A.C. McPherron, A.M. Lawler, and S.J. Lee Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member Nature 387 1997 83 90
61. L.A. Megeney, B. Kablar, K. Garrett, J.E. Anderson, and M.A. Rudnicki MyoD is required for myogenic stem cell function in adult skeletal muscle Genes Dev 10 1996 1173 1183
62. W.E. Mitch, and A.L. Goldberg Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway N Engl J Med 335 1996 1897 1905
63. D.E. Niewoehner, M.L. Erbland, R.H. Deupree, D. Collins, N.J. Gross, and R.W. Light Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group N Engl J Med 340 1999 1941 1947
64. R.A. Pauwels, and K.F. Rabe Burden and clinical features of chronic obstructive pulmonary disease (COPD) Lancet 364 2004 613 620
65. M.A. Pelleymounter, M.J. Cullen, M.B. Baker, R. Hecht, D. Winters, and T. Boone Effects of the obese gene product on body weight regulation in ob/ob mice Science 269 1995 540 543
66. S.R. Price, J.L. Bailey, X. Wang, C. Jurkovitz, B.K. England, and X. Ding Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription J Clin Invest 98 1996 1703 1708
67. R.A. Rabinovich, E. Ardite, T. Troosters, N. Carbo, J. Alonso, and J.M. Gonzalez de Suso Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 164 2001 1114 1118
68. A.Z. Reznick, O. Menashe, M. Bar-Shai, R. Coleman, and E. Carmeli Expression of matrix metalloproteinases, inhibitor, and acid phosphatase in muscles of immobilized hindlimbs of rats Muscle Nerve 27 2003 51 59
69. R. Rodriguez-Roisin Toward a consensus definition for COPD exacerbations Chest 117 2000 398S 401S
70. L.A. Sabourin, A. Girgis-Gabardo, P. Seale, A. Asakura, and M.A. Rudnicki Reduced differentiation potential of primary MyoD-/- myogenic cells derived from adult skeletal muscle J Cell Biol 144 1999 631 643
71. A.M. Schols, W.A. Buurman, A.J. Staal van den Brekel, M.A. Dentener, and E.F. Wouters Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease Thorax 51 1996 819 824
72. A.M. Schols, J. Slangen, L. Volovics, and E.F. Wouters Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 1998 1791 1797
73. T.A. Seemungal, G.C. Donaldson, E.A. Paul, J.C. Bestall, D.J. Jeffries, and J.A. Wedzicha Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 1998 1418 1422
74. M. Shintani, Y. Ogawa, K. Ebihara, M. Aizawa-Abe, F. Miyanaga, and K. Takaya Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway Diabetes 50 2001 227 232
75. M.A. Spruit, R. Gosselink, T. Troosters, A. Kasran, G. Gayan-Ramirez, and P. Bogaerts Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I Thorax 58 2003 752 756
76. N. Takabatake, H. Nakamura, S. Abe, T. Hino, H. Saito, and H. Yuki Circulating leptin in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 159 1999 1215 1219
77. T. Tsujinaka, J. Fujita, C. Ebisui, M. Yano, E. Kominami, and K. Suzuki Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice J Clin Invest 97 1996 244 249
78. J.A. Wedzicha, T.A. Seemungal, P.K. MacCallum, E.A. Paul, G.C. Donaldson, and A. Bhowmik Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels Thromb Haemost 84 2000 210 215
79. T.M. Wilkinson, G.C. Donaldson, J.R. Hurst, T.A. Seemungal, and J.A. Wedzicha Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease Am J Respir Crit Care Med 169 2004 1298 1303
80. S.C. Woods, R.J. Seeley, D. Porte Jr., and M.W. Schwartz Signals that regulate food intake and energy homeostasis Science 280 1998 1378 1383
81. E.F.M. Wouters Management of severe COPD Lancet 364 2004 883 895
82. Z. Yan, S. Choi, X. Liu, M. Zhang, J.J. Schageman, and S.Y. Lee Highly coordinated gene regulation in mouse skeletal muscle regeneration J Biol Chem 278 2003 8826 8836